These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Crystal structure of the pantothenate synthetase from Mycobacterium tuberculosis, snapshots of the enzyme in action. Wang S; Eisenberg D Biochemistry; 2006 Feb; 45(6):1554-61. PubMed ID: 16460002 [TBL] [Abstract][Full Text] [Related]
3. Active site residues in Mycobacterium tuberculosis pantothenate synthetase required in the formation and stabilization of the adenylate intermediate. Zheng R; Dam TK; Brewer CF; Blanchard JS Biochemistry; 2004 Jun; 43(22):7171-8. PubMed ID: 15170354 [TBL] [Abstract][Full Text] [Related]
4. A discovery of novel Mycobacterium tuberculosis pantothenate synthetase inhibitors based on the molecular mechanism of actinomycin D inhibition. Yang Y; Gao P; Liu Y; Ji X; Gan M; Guan Y; Hao X; Li Z; Xiao C Bioorg Med Chem Lett; 2011 Jul; 21(13):3943-6. PubMed ID: 21641210 [TBL] [Abstract][Full Text] [Related]
5. A comparison of the dynamics of pantothenate synthetase from M. tuberculosis and E. coli: computational studies. Tan YS; Fuentes G; Verma C Proteins; 2011 Jun; 79(6):1715-27. PubMed ID: 21425349 [TBL] [Abstract][Full Text] [Related]
6. The design and synthesis of inhibitors of pantothenate synthetase. Tuck KL; Saldanha SA; Birch LM; Smith AG; Abell C Org Biomol Chem; 2006 Oct; 4(19):3598-610. PubMed ID: 16990935 [TBL] [Abstract][Full Text] [Related]
8. Reaction intermediate analogues as bisubstrate inhibitors of pantothenate synthetase. Xu Z; Yin W; Martinelli LK; Evans J; Chen J; Yu Y; Wilson DJ; Mizrahi V; Qiao C; Aldrich CC Bioorg Med Chem; 2014 Mar; 22(5):1726-35. PubMed ID: 24507827 [TBL] [Abstract][Full Text] [Related]
9. A high-throughput screen against pantothenate synthetase (PanC) identifies 3-biphenyl-4-cyanopyrrole-2-carboxylic acids as a new class of inhibitor with activity against Mycobacterium tuberculosis. Kumar A; Casey A; Odingo J; Kesicki EA; Abrahams G; Vieth M; Masquelin T; Mizrahi V; Hipskind PA; Sherman DR; Parish T PLoS One; 2013; 8(11):e72786. PubMed ID: 24244263 [TBL] [Abstract][Full Text] [Related]
10. Structure-guided design of thiazolidine derivatives as Mycobacterium tuberculosis pantothenate synthetase inhibitors. Devi PB; Samala G; Sridevi JP; Saxena S; Alvala M; Salina EG; Sriram D; Yogeeswari P ChemMedChem; 2014 Nov; 9(11):2538-47. PubMed ID: 25155986 [TBL] [Abstract][Full Text] [Related]
11. Development of novel tetrahydrothieno[2,3-c]pyridine-3-carboxamide based Mycobacterium tuberculosis pantothenate synthetase inhibitors: molecular hybridization from known antimycobacterial leads. Samala G; Devi PB; Nallangi R; Sridevi JP; Saxena S; Yogeeswari P; Sriram D Bioorg Med Chem; 2014 Mar; 22(6):1938-47. PubMed ID: 24565972 [TBL] [Abstract][Full Text] [Related]
13. A novel isoform of pantothenate synthetase in the Archaea. Ronconi S; Jonczyk R; Genschel U FEBS J; 2008 Jun; 275(11):2754-64. PubMed ID: 18422645 [TBL] [Abstract][Full Text] [Related]
14. Application of fragment growing and fragment linking to the discovery of inhibitors of Mycobacterium tuberculosis pantothenate synthetase. Hung AW; Silvestre HL; Wen S; Ciulli A; Blundell TL; Abell C Angew Chem Int Ed Engl; 2009; 48(45):8452-6. PubMed ID: 19780086 [No Abstract] [Full Text] [Related]
15. Positional isotope exchange analysis of the pantothenate synthetase reaction. Williams L; Zheng R; Blanchard JS; Raushel FM Biochemistry; 2003 May; 42(17):5108-13. PubMed ID: 12718554 [TBL] [Abstract][Full Text] [Related]
16. Development of 3-phenyl-4,5,6,7-tetrahydro-1H-pyrazolo[4,3-c]pyridine derivatives as novel Mycobacterium tuberculosis pantothenate synthetase inhibitors. Samala G; Devi PB; Nallangi R; Yogeeswari P; Sriram D Eur J Med Chem; 2013 Nov; 69():356-64. PubMed ID: 24077526 [TBL] [Abstract][Full Text] [Related]
17. Substrate-induced closing of the active site revealed by the crystal structure of pantothenate synthetase from Staphylococcus aureus. Satoh A; Konishi S; Tamura H; Stickland HG; Whitney HM; Smith AG; Matsumura H; Inoue T Biochemistry; 2010 Aug; 49(30):6400-10. PubMed ID: 20568730 [TBL] [Abstract][Full Text] [Related]
18. Inhibition of Mycobacterium tuberculosis pantothenate synthetase by analogues of the reaction intermediate. Ciulli A; Scott DE; Ando M; Reyes F; Saldanha SA; Tuck KL; Chirgadze DY; Blundell TL; Abell C Chembiochem; 2008 Nov; 9(16):2606-11. PubMed ID: 18821554 [No Abstract] [Full Text] [Related]
19. Identification and development of 2-methylimidazo[1,2-a]pyridine-3-carboxamides as Mycobacterium tuberculosis pantothenate synthetase inhibitors. Samala G; Nallangi R; Devi PB; Saxena S; Yadav R; Sridevi JP; Yogeeswari P; Sriram D Bioorg Med Chem; 2014 Aug; 22(15):4223-32. PubMed ID: 24953948 [TBL] [Abstract][Full Text] [Related]
20. Crystal structures of a pantothenate synthetase from M. tuberculosis and its complexes with substrates and a reaction intermediate. Wang S; Eisenberg D Protein Sci; 2003 May; 12(5):1097-108. PubMed ID: 12717031 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]